Inhibrx
INBX
#5378
Rank
S$1.76 B
Marketcap
S$121.35
Share price
4.52%
Change (1 day)
506.02%
Change (1 year)

Market capitalization of Inhibrx (INBX)

Market cap: S$1.76 Billion

As of December 2025 Inhibrx has a market cap of S$1.76 Billion. This makes Inhibrx the world's 5378th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Inhibrx from 2020 to 2025

End of year Market Cap

Year Marketcap Change
2025S$1.76 B497.55%
2024S$0.29 B-87.56%
2023S$2.37 B64.98%
2022S$1.43 B-35.8%
2021S$2.24 B36.22%
2020S$1.64 B

End of Day market cap according to different sources

On Dec 7th, 2025 the market cap of Inhibrx was reported to be:

S$1.68 Billion
by Nasdaq info icon info icon
S$1.68 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
S$1.32 B-24.67%๐Ÿ‡บ๐Ÿ‡ธ USA